JANEEN WHITE: Open Payments
NPI 1861910655 · TORRINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,209 in 108 payments from 16 companies in 2025. Trend: 2023 $98 · 2024 $1,750 · 2025 $2,209
Food & beverage: $2,209
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 31 | $437 |
| AstraZeneca Pharmaceuticals LP | 15 | $372 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $245 |
| Insmed, Inc. | 9 | $204 |
| Amgen Inc. | 11 | $165 |
| Verona Pharma, Inc. | 8 | $148 |
| Grifols USA, LLC | 5 | $140 |
| Regeneron Healthcare Solutions, Inc. | 5 | $124 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $102 |
| Inspire Medical Systems, Inc. | 3 | $76 |
Products named: TEZSPIRE, NUCALA, GLASSIA, Arikayce, DUPIXENT, Ohtuvayre, Prolastin-C Liquid, TRELEGY ELLIPTA.
Industry payments across CT — which companies pay providers there.
